clinicaladvisor.com

Epclusa approved to treat chronic hepatitis C

HealthDay News — The combination drug Epclusa has been approved by the US Food and Drug Administration to treat the 6 major strains of chronic hepatitis C virus. Epclusa combines sofosbuvir, ...
Medscape

Clinicians Can Prescribe the Cure for Hepatitis C: Most Kids Never Get It

Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment. “HCV is a silent killer,” said Megan Rose Curtis, MD, MS, the lead author of the ...
Business Insider

Cocrystal Pharma Presents Positive Data from U.S. Phase 2a Study of CC-31244 Demonstrating Ability to Identify Patients More Likely to Respond to Ultrashort Treatment of HCV

- New data presented at the American Association for the Study of Liver Diseases (AASLD) 2019 Liver Meeting - - Patients that achieved SVR had significantly higher frequencies of terminally ...
Reuters

Gilead Sciences Canada says Ontario to list Epclusa on public drug plan to treat all six genotypes of chronic Hepatitis C infection

* Gilead Sciences Canada- effective feb 28, ontario to list epclusa on public drug plan to treat all six genotypes of chronic hepatitis c infection Source text for Eikon: Further company coverage: ...
Reuters

Gilead Sciences gets Canada approval for Hepatitis C treatment Epclusa

* Gilead receives approval in Canada for Epclusa (sofosbuvir/velpatasvir), the first once-daily pan-genotypic single tablet regimen for the treatment of chronic ...